tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
FDMT
4D Molecular Therapeutics
RESEARCH TOOLSreports

4D Molecular Therapeutics (FDMT) Financial Statements

513 Followers

4D Molecular Therapeutics Financial Overview

4D Molecular Therapeutics's market cap is currently $502.35M. The company's EPS TTM is $0.43; its P/E ratio is -3.10; 4D Molecular Therapeutics is scheduled to report earnings on March 18, 2026, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 85.21M$ 37.00K$ 20.72M$ 3.13M$ 18.04M
Gross Profit$ 77.58M$ 37.00K$ -76.37M$ -77.12M$ -43.32M
Operating Income$ -159.55M$ -187.84M$ -112.87M$ -110.03M$ -71.33M
EBITDA$ -151.92M$ -181.14M$ -108.66M$ -107.63M$ -69.81M
Net Income$ -140.11M$ -160.87M$ -100.84M$ -107.49M$ -71.32M
Balance Sheet
Cash & Short-Term Investments$ 402.65M$ 424.88M$ 288.23M$ 213.55M$ 247.78M
Total Assets$ 566.71M$ 560.38M$ 339.89M$ 261.85M$ 353.49M
Total Debt$ 21.41M$ 24.61M$ 14.67M$ 16.12M$ 16.45M
Net Debt$ -38.83M$ -124.73M$ -234.44M$ -36.23M$ -136.55M
Total Liabilities$ 61.05M$ 49.78M$ 32.06M$ 30.51M$ 34.38M
Stockholders' Equity$ 505.66M$ 510.61M$ 307.83M$ 231.34M$ 319.11M
Cash Flow
Free Cash Flow$ -109.08M$ -138.37M$ -78.56M$ -98.22M$ -78.24M
Operating Cash Flow$ -109.08M$ -134.59M$ -75.79M$ -86.69M$ -69.13M
Investing Cash Flow$ -92.97M$ -302.44M$ 115.72M$ -17.05M$ -172.68M
Financing Cash Flow$ 112.96M$ 337.25M$ 156.83M$ 3.08M$ 118.09M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

Income Statement >

4D Molecular Therapeutics Debt to Assets

Balance Sheet >

4D Molecular Therapeutics Cash Flow

Cash Flow >

4D Molecular Therapeutics Forecast EPS vs Actual EPS

Earnings >